Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire Health Report.
Press releases published on June 9, 2025
Micron Biomedical Names Health Education and Empowerment Advocate, Dr. Jayne Morgan, to Board of Advisors
GlobeNewswire
·
June 9, 2025
ATLANTA, June 09, 2025 (GLOBE NEWSWIRE) -- Micron Biomedical, a life science company commercializing needle-free and fully dissolvable technology that simplifies and improves the transport, storage, and administration of drugs and vaccines, today announced …
Longeveron® to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
GlobeNewswire
·
June 9, 2025
MIAMI, June 09, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that Wa’el Hashad …
Circuit Clinical Solutions Inc. [“Circuit Clinical”] and Lightship Inc. [“Lightship”] Announce Strategic Merger to Accelerate Scale and Expanded Access in Clinical Research
GlobeNewswire
·
June 9, 2025
BUFFALO, N.Y. and MORRISVILLE, N.C., June 09, 2025 (GLOBE NEWSWIRE) -- Today, Lightship and Circuit Clinical proudly announce their strategic merger, forming a leading, unified force in clinical trial delivery. This landmark collaboration represents a …
Ambio Life Sciences Launches World's First Clinical Ibogaine Program for Patients With Neurodegenerative Conditions
GlobeNewswire
·
June 9, 2025
Facilities and care team tailored for patients with complex medical needs Specialized protocol includes optimized dosing and therapeutic support for patients with conditions like Parkinson's and multiple sclerosis Initial cohort of patients includes …
MD Anderson and HealthEx Announce Collaboration to Develop New Platform to Give Patients Direct Control of Data Access
GlobeNewswire
·
June 9, 2025
HOUSTON and SAN FRANCISCO, June 09, 2025 (GLOBE NEWSWIRE) -- The University of Texas MD Anderson Cancer Center and HealthEx today announced a strategic collaboration aimed at developing tools for streamlining the patient consent process while also creating …
Tevogen Expands Headquarters Amid Growth of AI and Generics & Biosimilars Initiatives
GlobeNewswire
·
June 9, 2025
R…
AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL
GlobeNewswire
·
June 9, 2025
VALENCIA, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today highlighted data presented by researchers at the British Burn …
BriefCast Publishes Transcript: PolyPid Ltd. SHIELD II Phase 3 Trial Topline Results Call Transcript
GlobeNewswire
·
June 9, 2025
In a call hosted today, June 9, 2025, PolyPid Ltd. unveiled highly successful topline results from its SHIELD II Phase 3 trial of D-PLEX100 for preventing surgical site infections (SSIs) in abdominal colorectal surgery patients with large incisions. The …
Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV
GlobeNewswire
·
June 9, 2025
National TV Segment Highlights FDA-Approved Treatment for Rosacea Segment premiered on Monday, June 9 and will be rebroadcast on Thursday, June 19, at 7:30 a.m. PT/ ET SCOTTSDALE, Ariz., June 09, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq …
Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System
GlobeNewswire
·
June 9, 2025
HINGHAM, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY Endovascular Robotic System, today announced the continued expansion of its commercial team in preparation for the anticipated U.S. …
Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors
GlobeNewswire
·
June 9, 2025
SAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the appointment of Bernd Brust as Chief …
Catheter Precision, Inc. Secures VIVO Purchase Order From Sahlgrenska University Hospital
GlobeNewswire
·
June 9, 2025
FORT MILL, S.C., June 09, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced receipt of the …
FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial Officer
GlobeNewswire
·
June 9, 2025
HOUSTON, June 09, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic …
LifeMD to Participate in Two Investor Conferences During June
GlobeNewswire
·
June 9, 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of June: BTIG Obesity …
Beacon Therapeutics Strengthens Leadership Team with the Appointment of Dr. Daniel Chung as Chief Medical Officer
GlobeNewswire
·
June 9, 2025
LONDON and CAMBRIDGE, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics’ or ‘the Company’), a leading clinical-stage biotechnology company with a mission to save and restore the vision of patients with …
OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development
GlobeNewswire
·
June 9, 2025
Will provide expertise across ModeX’s portfolio of next generation multispecific antibodies for complex diseases involving the immune system, including cancer ModeX’s promising immunology pipeline includes first-in class drugs with two assets in ongoing …
Viemed Healthcare Announces Share Repurchase Program
GlobeNewswire
·
June 9, 2025
LAFAYETTE, La., June 09, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader of in-home, technology-enabled post-acute respiratory care, today announced that its Board of Directors has authorized a …
Results from Humacyte’s V007 Pivotal Phase 3 AV Access Study Highlighted by Presentation at the Society for Vascular Surgery Meeting
GlobeNewswire
·
June 9, 2025
DURHAM, N.C., June 09, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, announced today that the results from its …
PDS Biotech to Host Key Opinion Leader Event to Discuss Versamune® HPV for the Treatment of HPV16+ HNSCC
GlobeNewswire
·
June 9, 2025
Event to Discuss the Changing Landscape of HNSCC in context with the Merck KN-689 study and the Rapidly Increasing Incidences of HPV16-positive HNSCC in the United States and Europe Webinar to be held Tuesday, June 17, 2025, 12:00 PM ET PRINCETON, N.J., …
Provectus Biopharmaceuticals Announces Investor Webinar for 2025 Annual Meeting of Stockholders
GlobeNewswire
·
June 9, 2025
KNOXVILLE, Tenn., June 09, 2025 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) announced today that its 2025 annual stockholder meeting (the “Annual Meeting”), including shareholder meeting activities …